Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Polyps in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Johnson, Christine Cole; Hayes, Richard B.; Schoen, Robert E.; Gunter, Marc J.; Wen-Yi Huang
December 2010
American Journal of Gastroenterology;Dec2010, Vol. 105 Issue 12, p2646
Academic Journal
OBJECTIVES:Non-steroidal anti-inflammatory drugs (NSAIDs) have been documented in animal and human studies to reduce risk for colorectal cancer and adenomatous polyps, but risk modification for subgroups of the population and effects on hyperplastic polyps have been less studied.METHODS:Data on recent use of two frequently ingested NSAIDs, aspirin and ibuprofen, were collected at baseline from participants aged 55-74 years in the 10 centers of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). Participants randomized to the intervention arm of the trial received a flexible sigmoidoscopy during a baseline examination. Follow-up of detected polyps was accomplished outside the Trial setting and relevant records were sought and abstracted. Cases (n=4,017) included subjects with a biopsy-proven polyp in the left side of the colon (descending colon, sigmoid, and rectum) detected as a consequence of PLCO screening; controls (n=38,396) were subjects with no left-sided colon polyp.RESULTS:Regular use of aspirin (≥4 times/month) in the past year was inversely associated with hyperplastic polyps (odds ratios (OR)=0.8, 95% confidence interval (CI)=0.7-0.9), adenomatous polyps (OR=0.8, 95% CI=0.8-0.9), and advanced adenomas (OR=0.8, 95% CI=0.7-0.9). As frequency of aspirin use increased, the prevalence of polyps decreased significantly for each histological classification (P for trend ≤0.0004). Similar patterns were found for adenomas and ibuprofen. Overall protection was consistent in both the descending colon or sigmoid and the rectum, but more evident in males. In males, the OR for heavy use of combined aspirin and ibuprofen (≥2 times/day) was 0.6 (95% CI=0.5-0.8), as opposed to 0.9 (95% CI=0.8-1.1) in females. The protective effects of NSAIDs for females were apparent only among those with body mass index (BMI) <25 (OR=0.8, 95% CI=0.7-1.0 for regular use of NSAIDs; P interaction=0.04). We also found a slightly stronger protection of NSAIDs in the 70-74 years age group compared with those aged 55-69 years.CONCLUSIONS:This study of a large general risk population supports previous work that recent use of aspirin and ibuprofen is associated with a decreased risk of colorectal adenomas and demonstrates that this protective effect may be stronger in certain population subgroups and is also evident for aspirin and hyperplastic polyps.


Related Articles

  • Fifty years since the discovery of ibuprofen. Rainsford, K. // Inflammopharmacology;Dec2011, Vol. 19 Issue 6, p293 

    The author summarizes the history of the discovery of ibuprofen at the Boots Co. in Great Britain. He notes that the discovery of the drug was based on the need to have a safer form of aspirin without its gastrointestinal effects and also without the serious adverse effects of phenylbutazone and...

  • Aspirin/ibuprofen/paracetamol.  // Reactions Weekly;1/6/2007, Issue 1133, p7 

    The article reports on the case of a 25-year-old man who had developed respiration disorders during treatment with ibuprofen, paracetamol and aspirin. A description of the patient's symptoms is provided. The outcome of the aspirin challenge and desensitization with concomitant prednisone which...

  • Screening Sigmoidoscopy: Can the Road to Colonoscopy Be Less Traveled? Winawer, Sidney J. // Annals of Internal Medicine;12/16/2003, Vol. 139 Issue 12, p1034 

    Analyzes the various aspects of sigmoidoscopy in the early detection of colorectal cancer. Role of virtual colonoscopy; Variance of risk factors; Link between adenomas and colorectal cancer; Significance of biopsy on small polyps; Concept of selective colonoscopy.

  • Acetaminophen.  // Body Bulletin;Apr2004, Vol. 5 Issue 4, p1 

    The article presents information about Acetaminophen, a pain killer. Acetaminophen relieves pain but not inflammation. Nonsteroidal anti-inflammatory drugs, which include aspirin and ibuprofen, reduce both pain and inflammation and are especially helpful for joint and muscle aches. But both...

  • US FDA warns about ibuprofen and aspirin interaction.  // Reactions Weekly;9/16/2006, Issue 1119, p2 

    The article reports on the warning of the U.S. Food and Drug Administration (FDA) about the potential interaction between ibuprofen and low-dose, nonenteric coated aspirin. The effect of the drug interaction on myocardial infarction patients is considered. The impact of ibuprofen on the...

  • Ibuprofen.  // Reactions Weekly;2/6/2010, Issue 1287, p24 

    The article describes the case of a woman who developed Kounis syndrome after being treated with ibuprofen postpartum.

  • Ibuprofen.  // Reactions Weekly;2/4/2012, Issue 1387, p21 

    The article describes a case of fetal intracranial haemorrhage and stillbirth following ibuprofen use.

  • Ibuprofen.  // Reactions Weekly;5/19/2012, Issue 1402, p28 

    The article describes the case of a 74-year-old man who developed mesenteric panniculitis caused by ibuprofen-associated duodenitis.

  • Ibuprofen.  // Reactions Weekly;8/11/2012, Issue 1414, p29 

    The article describes the case of a 62-year-old man who developed enteropathy following treatment with ibuprofen for headaches.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics